As the action in the CBD space starts to heat back up, traders may benefit from taking note that cbdMD Inc (NYSEAMERICAN:YCBD) just announced that it has filed a new patent application with the U.S. Patent and Trademark Office which will allow it to pursue patented protection in several key areas, including novel formulations and delivery systems, as well as methods of manufacturing and use.
According to the release, the recent submission by the company is part of its ongoing intellectual property strategy to ensure appropriate protection around its product lines and to be forward-thinking as to the direction of the CBD market.
cbdMD Inc (NYSEAMERICAN:YCBD) promulgates itself as a company that produces and distributes various cannibidiol (CBD) products.
It owns and operates the consumer hemp-based CBD brand, cbdMD. The company’s product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name.
The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.
According to company materials, cbdMD, Inc. is one of the leading, most trusted and most recognized cannabidiol (CBD) consumer brands, whose current products include CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs and CBD pet products. cbdMD is also a proud partner of Bellator MMA and Life Time, Inc., and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.”
Find out when $YCBD reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, YCBD just announced that it has filed a new patent application with the U.S. Patent and Trademark Office which will allow it to pursue patented protection in several key areas, including novel formulations and delivery systems, as well as methods of manufacturing and use.
Traders will note 75% tacked on to share pricing for the company in the past month. In addition, the listing has seen a growing influx of trading interest, with the stock’s recent average trading volume running 60% over the long run average.
“cbdMD has always been a leader of innovation the CBD industry. Pursuing intellectual property will remain a priority for us as we continue to strengthen and grow the company’s assets within a fiscally disciplined mindset,” said Martin A. Sumichrast, Chairman and co-CEO at cbdMD, Inc. “The filing of this new patent application furthers supports our mission of being a preeminent science-based company in a currently congested CBD marketplace. Continued research and development for real world applications drives innovation and protecting those proprietary technologies and ideas is consistent with cbdMD’s business plan. We look forward to our future innovation and continuing to pursue additional IP protection.”
Now commanding a market cap of $140M, YCBD has a significant war chest ($14.9M) of cash on the books, which must be weighed relative to about $5.8M in total current liabilities. One should also note that debt has been growing over recent quarters. YCBD is pulling in trailing 12-month revenues of $36.3M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 65.7%. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $YCBD stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $YCBD, either long or short, and we have not been compensated for this article.